Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen T Warren

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Developmental Cell|December 29, 2004
Fragile X protein functions with lgl and the par complex in flies and miceDaniela C Zarnescu, Peng Jin, Joerg Betschinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizuresLeila K Myrick, Pan-Yue Deng, Hideharu Hashimoto, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 23, 2015
Genome-wide association study of schizophrenia in Ashkenazi JewsFernando S Goes, John McGrath, Dimitrios Avramopoulos, et al.
Stem Cell Reports|March 28, 2014
Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogrammingGengzhen Zhu, Yujing Li, Fei Zhu, et al.
American Journal of Human Genetics|August 10, 2010
Microdeletions of 3q29 confer high risk for schizophreniaJennifer Gladys Mulle, Anne F Dodd, John A McGrath, et al.
Molecular Autism|July 11, 2018
Case-control meta-analysis of blood DNA methylation and autism spectrum disorderShan V Andrews, Brooke Sheppard, Gayle C Windham, et al.
Molecular Psychiatry|April 13, 2019
Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletionTimothy P Rutkowski, Ryan H Purcell, Rebecca M Pollak, et al.
Plos Genetics|November 22, 2011
Relative burden of large CNVs on a range of neurodevelopmental phenotypesSanthosh Girirajan, Zoran Brkanac, Bradley P Coe, et al.
Science Translational Medicine|September 21, 2012
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofenChristina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, et al.
Translational Psychiatry|February 18, 2022
Metabolic effects of the schizophrenia-associated 3q29 deletionRebecca M Pollak, Ryan H Purcell, Timothy P Rutkowski, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Developmental Cell|December 29, 2004
Fragile X protein functions with lgl and the par complex in flies and miceDaniela C Zarnescu, Peng Jin, Joerg Betschinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizuresLeila K Myrick, Pan-Yue Deng, Hideharu Hashimoto, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 23, 2015
Genome-wide association study of schizophrenia in Ashkenazi JewsFernando S Goes, John McGrath, Dimitrios Avramopoulos, et al.
Stem Cell Reports|March 28, 2014
Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogrammingGengzhen Zhu, Yujing Li, Fei Zhu, et al.
American Journal of Human Genetics|August 10, 2010
Microdeletions of 3q29 confer high risk for schizophreniaJennifer Gladys Mulle, Anne F Dodd, John A McGrath, et al.
Molecular Autism|July 11, 2018
Case-control meta-analysis of blood DNA methylation and autism spectrum disorderShan V Andrews, Brooke Sheppard, Gayle C Windham, et al.
Molecular Psychiatry|April 13, 2019
Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletionTimothy P Rutkowski, Ryan H Purcell, Rebecca M Pollak, et al.
Plos Genetics|November 22, 2011
Relative burden of large CNVs on a range of neurodevelopmental phenotypesSanthosh Girirajan, Zoran Brkanac, Bradley P Coe, et al.
Science Translational Medicine|September 21, 2012
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofenChristina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, et al.
Translational Psychiatry|February 18, 2022
Metabolic effects of the schizophrenia-associated 3q29 deletionRebecca M Pollak, Ryan H Purcell, Timothy P Rutkowski, et al.
Pageof 10